Defang Li
Assistant Professor
Department of Advancing Translational Medicine in Bone & Joi
Institute of Integrated Bioinformedicine and Translational Science
Hong Kong
Biography
Academic qualifications 2003-2007: B. S. College of pharmacy, Shihezi University, Shihezi, China 2007-2010: M. M. College of pharmacy, Shihezi University, Shihezi, China 2010-2013: Sc. D. College of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing, and 1 Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China Previous academic positions held 2013-2015: Research Assistant, Academician Chen Xinzi Workroom for Advancing Translational Medicine in Bone & Joint Diseases, Kunshan RNAi Institute, Kunshan Industrial Technology Research Institute, Kunshan, Jiangsu, China. Present academic position: 2015- Research assistant professor, Institute for Advancing Translational Medicine in Bone & Joint Diseases, Hong Kong Baptist University & Teaching Division, School of Chinese Medicine, Hong Kong Baptist University
Research Interest
Molecular understandings and RNAi-based & phytotherapy-based translational research aortic dissection
Publications
-
Liu J, Dang L, Li D, Liang C, He X, Wu H, Qian A, Yang Z, Au DW, Chiang MW, Zhang BT. A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts. Biomaterials. 2015 Jun 30;52:148-60.
-
Shaikh AB, Li F, Li M, He B, He X, Chen G, Guo B, Li D, Jiang F, Dang L, Zheng S. Present advances and future perspectives of molecular targeted therapy for osteosarcoma. International journal of molecular sciences. 2016 Apr 6;17(4):506.
-
Li D, Liu J, Guo B, Liang C, Dang L, Lu C, He X, Cheung HY, Xu L, Lu C, He B. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nature communications. 2016 Mar 7;7.
-
Yu L, Ma J, Han J, Wang B, Chen X, Gao C, Li D, Zheng Q. Licochalcone B Arrests Cell Cycle Progression and Induces Apoptosis in Human Breast Cancer MCF-7 Cells. Recent patents on anti-cancer drug discovery. 2016 Nov 1;11(4):444-52.
